Related references
Note: Only part of the references are listed.Advanced glycation end products induce oxidative stress and mitochondrial dysfunction in SH-SY5Y cells
Xu Wang et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2015)
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
Surapon Tangvarasittichai
WORLD JOURNAL OF DIABETES (2015)
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Kerstin Nowotny et al.
BIOMOLECULES (2015)
Step counter use in type 2 diabetes: a meta-analysis of randomized controlled trials
Shanhu Qiu et al.
BMC MEDICINE (2014)
Impact of Walking on Glycemic Control and Other Cardiovascular Risk Factors in Type 2 Diabetes: A Meta-Analysis
Shanhu Qiu et al.
PLOS ONE (2014)
Prevalence and Control of Diabetes in Chinese Adults
Yu Xu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes
Daniela Gradinaru et al.
JOURNAL OF PROTEOMICS (2013)
Increasing Prevalence of Type 2 Diabetes in Chinese Adults in Shanghai
Rui Li et al.
DIABETES CARE (2012)
Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial
R. C. Andrews et al.
LANCET (2011)
Performance of an A1C and Fasting Capillary Blood Glucose Test for Screening Newly Diagnosed Diabetes and Pre-Diabetes Defined by an Oral Glucose Tolerance Test in Qingdao, China
Xianghai Zhou et al.
DIABETES CARE (2010)
Prevalence of Diabetes among Men and Women in China
Wenying Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Dietary Advanced Glycation End Products and Aging
Claudia Luevano-Contreras et al.
NUTRIENTS (2010)
Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: cross sectional epidemiological survey
Yuqian Bao et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Prevalence and risk factors for type 2 diabetes mellitus in the Chinese adult population: The InterASIA Study
Dongsheng Hu et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
Low yield of population-based screening for Type 2 diabetes in the Netherlands: the ADDITION Netherlands study
P. G. H. Janssen et al.
FAMILY PRACTICE (2007)
Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance - The Australian diabetes, obesity, and lifestyle study (AusDiab)
Elizabeth L. M. Barr et al.
CIRCULATION (2007)
Advanced glycation end products - Sparking the development of diabetic vascular injury
Alison Goldin et al.
CIRCULATION (2006)
Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative
PM Bossuyt et al.
ANNALS OF INTERNAL MEDICINE (2003)
Using HbA1c to improve efficacy of the American Diabetes Association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians -: The Strong Heart Study
WY Wang et al.
DIABETES CARE (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The determination of AGE-peptides by flow injection assay, a practical marker of diabetic nephropathy
ZL Sun et al.
CLINICA CHIMICA ACTA (2001)
HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic of levels at fasting plasma glucose -: The Early Diabetes Intervention Program (EDIP)
RC Perry et al.
DIABETES CARE (2001)
Concordance between fasting and 2-h post-glucose challenge criteria for the diagnosis of diabetes mellitus and glucose intolerance in high risk individuals
J Drzewoski et al.
DIABETIC MEDICINE (2001)
The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy
T Shimoike et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)